Life-Threatening Anaphylactoid Reaction in an Acute Ischemic Stroke Patient With Intravenous rt-PA Thrombolysis, Followed by Successful Intra-Arterial Thrombolysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
An anaphylactoid reaction to recombinant tissue plasminogen activator (rt-PA) is an uncommon but fatal complication. A 39-year-old man was admitted within 1 hour of the onset of a right hemispheric stroke. He was not taking any specific medication, including angiotensin-converting enzyme (ACE) inhibitors. A systemic anaphylactoid reaction developed immediately after rt-PA infusion. However, the symptoms were improved after treatment with a steroid and antihistamine. Subsequent intra-arterial thrombolytic therapy resulted in complete recanalization and clinical improvement. To our knowledge, this is the first report of a life-threatening anaphylactoid reaction after rt-PA treatment followed by successful intra-arterial thrombolytic therapy in a patient who had not taken an ACE inhibitor.
Abstract
An anaphylactoid reaction to recombinant tissue plasminogen activator (rt-PA) is an uncommon but fatal complication. A 39-year-old man was admitted within 1 hour of the onset of a right hemispheric stroke. He was not taking any specific medication, including angiotensin-converting enzyme (ACE) inhibitors. A systemic anaphylactoid reaction developed immediately after rt-PA infusion. However, the symptoms were improved after treatment with a steroid and antihistamine. Subsequent intra-arterial thrombolytic therapy resulted in complete recanalization and clinical improvement. To our knowledge, this is the first report of a life-threatening anaphylactoid reaction after rt-PA treatment followed by successful intra-arterial thrombolytic therapy in a patient who had not taken an ACE inhibitor.
참고문헌 (13)
- Hill MD, "Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke", Can Med Assoc J, 162, pp.1281~1284 (2000)
- Krmpotic KR, "Anaphylactoid reaction to recombinant tissue plasminogen activator", Eur J Emerg Med, 14, pp.60~61 (2007)
- Hill MD, "Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke", Neurology, 60, pp.1525~1527 (2003)
- . Pancioli A, "Asymmetric angioneurotic edema associated with thrombolysis for acute stroke", Ann Emerg Med, 30, pp.227~229 (1997)
- Rudolf J, "Orolingual angioneurotic edema following therapy of acute ischemic stroke with alteplase", Neurology, 55, pp.599~600 (2000)
- Engelter ST, "Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke", J Neurol, 252, pp.1167~1170 (2005)
- Adams HP Jr, "Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association", American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists, 2007, pp.38, 1655~1711
- "Tissue plasminogen activator for acute ischemic stroke", N Engl J Med, 333, pp.1581~1587 (1995), The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
- Massel D, "Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction", Can J Cardiol, 7, pp.298~302 (1991)
- Cugno M, "Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein", Thromb Haemost, 76, pp.234~238 (1996)
- Rudolf J, "Evidence of anaphylaxy following alteplase infusion", Stroke, 30, pp.1142~1143 (1999)
- Bennett WR, "Activation of the complement system by recombinant tissue plasminogen activator", J Am Coll Cardiol, 10, pp.627~632 (1987)
- Rha JH, "The impact of recanalization on ischemic stroke outcome: a meta-analysis", Stroke, 38, pp.967~973 (2007)